Zobrazeno 1 - 10
of 46
pro vyhledávání: '"D R Mack"'
Autor:
E Kuenzig, H Singh, A Bitton, G G Kaplan, M W Carroll, A R Otley, T A Stukel, S Spruin, A M Griffiths, D R Mack, K Jacobson, G C Nguyen, L E Targownik, W El-Matary, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:34-35
Background In Canada, the incidence of inflammatory bowel disease (IBD) is increasing faster among those Purpose To compare healthcare utilization and risk of surgery among children diagnosed with IBD across age groups defined by the Paris Classifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acef319efd580572530e7a20c8016e74
https://doi.org/10.1093/jcag/gwac036.189
https://doi.org/10.1093/jcag/gwac036.189
Autor:
E Kuenzig, R Duchen, T D Walters, D R Mack, A M Griffiths, C N Bernstein, G G Kaplan, A R Otley, W Yu, X Wang, J Guan, S Fung, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:26-27
Background The incidence of inflammatory bowel disease (IBD) continues to rise rapidly among Canadian children. The care of children results in higher direct healthcare costs than adults with IBD. It is imperative that we identify individuals who wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5777bae7f9acda920f6c4b9d9f3a99ea
https://doi.org/10.1093/jcag/gwac036.182
https://doi.org/10.1093/jcag/gwac036.182
Autor:
E Kuenzig, H Singh, A Bitton, G G Kaplan, M W Carroll, A R Otley, T A Stukel, S Spruin, A M Griffiths, D R Mack, K Jacobson, G C Nguyen, L E Targownik, W El-Matary, S Nasiri, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:27-28
Background Marked variation in access to care and health services utilization is a marker of variation in quality of care. With the rising incidence of pediatric inflammatory bowel disease (IBD), we must understand variation in access to and outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdf72815bbe0924fdbf81259ca0ba749
https://doi.org/10.1093/jcag/gwac036.183
https://doi.org/10.1093/jcag/gwac036.183
Autor:
S Lee, J Raygoza Garay, W Turpin, M I Smith, A Goethel, A Griffiths, P Moayyedi, O Espin-Garcia, G Aumais, C N Bernstein, I Avni-Biron, M Cino, C Deslandres, I Dotan, W El-Matary, B G Feagan, D S Guttmen, H Q Huynh, J Hyams, K Jacobson, D R Mack, J Marshall, A Otley, R Panaccione, M S Silverberg, H Steinhart, D Turner, W Xu, K Croitoru
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:127-129
Background Microbial composition-based risk score (MRS) was recently developed and validated to predict future risk of developing Crohn’s disease (CD) among healthy first-degree relatives (FDR) of CD patients. We hypothesized that stool metabolomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::274b5b1d9659cf0bf0de60dfcf78bd9f
https://doi.org/10.1093/jcag/gwab049.235
https://doi.org/10.1093/jcag/gwab049.235
Autor:
W El-Matary, J Witt, C N Bernstein, K Jacobson, D R Mack, A Otley, T Walters, H Q Huynh, J deBruyn, A Griffiths, E I Benchimol
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:26-27
Background Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::222d5982270adf315aab67f0102062cf
https://doi.org/10.1093/jcag/gwab049.022
https://doi.org/10.1093/jcag/gwab049.022
Autor:
A Neustaeter, J Timpano, S Lee, M Xue, H Leibovitzh, K Madsen, J Meddings, O Espin-Garcia, A Goethel, A Griffiths, P Moayyedi, H Steinhart, R Panaccione, H Q Huynh, K Jacobson, G Aumais, D R Mack, C N Bernstein, J Marshall, W Xu, W Turpin, K Croitoru
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:32-33
Background The Mediterranean Diet (MD) is proposed to reduce the risk of Crohn’s disease (CD) onset in cohort studies, with inconsistent results. This inconsistency may be due to heterogeneity in defining MD scores. Additionally, relationships betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2fa27e95af32dfb408f542e958ad00b
https://doi.org/10.1093/jcag/gwab049.156
https://doi.org/10.1093/jcag/gwab049.156
Autor:
P Dobranowski, H Qin, K Walker, J Butcher, A Gowing, R Singleton, J Mayne, D R Mack, D Figeys, A Stintzi
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:125-126
Background Gut microbes degrade and ferment resistant starch (RS) into metabolites that help maintain gut homeostasis. Clinical trials have evaluated RS for various health conditions, but individuals respond to RS with profound variability. The reaso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49c0737a62c7c74b36367149b4afe9d0
https://doi.org/10.1093/jcag/gwab049.233
https://doi.org/10.1093/jcag/gwab049.233
Autor:
H Leibovitzh, S Lee, M Xue, J Raygoza Garay, C Hernandez-Rocha, K Madsen, J Meddings, D S Guttmen, O Espin Garcia, A Goethel, A Griffiths, P Moayyedi, H Q Huynh, K Jacobson, D R Mack, M Abreu, C N Bernstein, J Marshall, D Turner, W Xu, W Turpin, K Croitoru
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:130-131
Background The gut microbiome may play a role in gut barrier homeostasis including epithelial barrier function, but data are scarce and limited to animal studies Aims To assess if alterations in gut microbiome are associated with gut barrier function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::009280e6074e74cfe72fef37c6cd2ba1
https://doi.org/10.1093/jcag/gwab049.237
https://doi.org/10.1093/jcag/gwab049.237
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:124-125
Background Both Celiac disease (CE) and inflammatory bowel disease (IBD) are lifelong gastrointestinal tract (GIT) disorders. CE is an autoimmune disorder triggered by gluten consumption and can result in small intestine villus atrophy, crypt hyperpl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f4f2d86fe88daf5b8e3e4199ff991cf
https://doi.org/10.1093/jcag/gwab049.232
https://doi.org/10.1093/jcag/gwab049.232
Autor:
R Hansen, S Meade, F Torrente, J Kammermeier, N M Croft, L de Ridder, D C Wilson, R Klomberg, D Turner, J Martín-de-Carpi, J Bronsky, E Benchimol, J Amil-Dias, D R Mack, G Walker, M Powar, N Burgess, C H van Ommen, P M Irving, M Samaan
Publikováno v:
Journal of Crohn's and Colitis. 16:i526-i527
Background Thromboprophylaxis is routinely used in adults with active inflammatory bowel disease (IBD), particularly inpatients, but not in children. Current ECCO/ESPGHAN guidelines support thromboprophylaxis only in children with acute severe coliti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::959309c188adf25cf03dafd089c4c032
https://doi.org/10.1093/ecco-jcc/jjab232.716
https://doi.org/10.1093/ecco-jcc/jjab232.716